Investment Summary

US Capital Global Invests In Andira

On June 14, 2023, merchant bank US Capital Global invested in life science company Andira

Investment Highlights
  • This is US Capital Global’s 1st transaction in the Life Science sector.
  • This is US Capital Global’s 1st transaction in Canada.
  • This is US Capital Global’s 1st transaction in British Columbia.

Investment Summary

Date 2023-06-14
Target Andira
Sector Life Science
Investor(s) US Capital Global
Deal Type Growth Capital

Target

Andira

Vancouver, British Columbia, Canada
Andira is a privately held health science firm that leverages natural cannabinoid compounds to accelerate the delivery of urgently needed medical solutions both for consumer care and hospital-based indications. Andira is based in Vancouver, British Columbia.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

DESCRIPTION

US Capital Global is an investment group as well as financial advisory firm focused on serving middle-market growth companies across the US. US Capital is sector agnostic and helps companies with capital raising, M&A, and other advisory services. US Capital Global was founded in 1998 and is based in San Francisco, California.


DEAL STATS #
Overall 2 of 2
Sector (Life Science) 1 of 1
Type (Growth Capital) 1 of 1
State (British Columbia) 1 of 1
Country (Canada) 1 of 1
Year (2023) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-01-27 Fulham

Hawthorne, California, United States

Fulham is a manufacturer of lighting components for use in commercial applications across various end markets including general lighting, emergency lighting, ultraviolet, and horticulture. Fulham was founded in 1994 and is based in Hawthorne, California.

Sell -